Accounting for the placebo response in cost-effectiveness analysis

被引：0
|
作者：
McDonald, H. P. [1 ]
Rebeira, M. [1 ]
Wright, S. [2 ]
Jaszewski, B. [1 ]
机构：
[1] Bayer Inc, Toronto, ON, Canada
[2] GW Pharma Ltd, Salisbury, Wilts, England
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70546-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A172 / A172
页数：1
相关论文
共 50 条
  • [1] Accounting for Cured Patients in Cost-Effectiveness Analysis
    Othus, Megan
    Bansal, Aasthaa
    Koepl, Lisel
    Wagner, Samuel
    Ramsey, Scott
    VALUE IN HEALTH, 2017, 20 (04) : 705 - 709
  • [2] Accounting for future costs in medical cost-effectiveness analysis
    Meltzer, D
    JOURNAL OF HEALTH ECONOMICS, 1997, 16 (01) : 33 - 64
  • [3] Cost-Effectiveness Analysis: Discount the Placebo at Your Peril
    Hawkins, Neil
    Scott, David A.
    MEDICAL DECISION MAKING, 2010, 30 (05) : 536 - 543
  • [4] COST ACCOUNTING - THE VITAL LINK TO COST-EFFECTIVENESS
    JANKE, TA
    JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1980, 77 (02) : 167 - 170
  • [5] Survivor costs in cost-effectiveness analysis - Response
    Golan, Y
    Wong, JB
    Pauker, SG
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (07) : 535 - 535
  • [6] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF CARE
    HIMMELSTEIN, DU
    WOOLHANDLER, S
    BOR, DH
    CLINICAL RESEARCH, 1987, 35 (03): : A744 - A744
  • [7] Cost-Effectiveness Analysis in Development: Accounting for Local Costs and Noisy Impacts
    Evans, David K.
    Popova, Anna
    WORLD DEVELOPMENT, 2016, 77 : 262 - 276
  • [8] Cost-effectiveness analysis of nivolumab versus placebo for relapsed malignant mesothelioma
    Wenwang Lang
    Jiarong Wei
    Qinling Jiang
    Qi Ai
    Xianling Zhao
    Liang Xiao
    Yulong He
    International Journal of Clinical Pharmacy, 2024, 46 : 158 - 165
  • [9] Cost-effectiveness analysis of nivolumab versus placebo for relapsed malignant mesothelioma
    Lang, Wenwang
    Wei, Jiarong
    Jiang, Qinling
    Ai, Qi
    Zhao, Xianling
    Xiao, Liang
    He, Yulong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (01) : 56 - 69
  • [10] Cost-effectiveness analysis
    Stein, Sherman C.
    Malhotra, Neil R.
    Burnett, Mark G.
    JOURNAL OF NEUROSURGERY-SPINE, 2014, 20 (04) : 474 - 474
12345